What HRT can fix, and what it can’t

You’re being asked to decide about hormone therapy on bad information from both directions.

One side has spent twenty years telling you it causes breast cancer. The other now sells it as a fountain of youth. Between them sits a woman who wants to know one thing: will it help me?

Here’s the short version. Hormone therapy is very good at a small number of things, does nothing for most of the rest, and is safer for many women than the last two decades of fear suggested. It is also not a permanent solution — and whatever you decide about it, the larger part of your symptom list needs a different kind of work.

What it treats

Hormone therapy is approved for a short and specific list. Which uses apply depends on the product — no single formulation carries all of them:

• Moderate to severe hot flashes and night sweats
• Vulvar and vaginal symptoms of menopause
• Prevention of osteoporosis after menopause, for some products
• Very low estrogen from conditions such as primary ovarian failure or surgical loss of the ovaries¹

Set that against what we covered in Falling estrogen is a weak explanation. The two symptoms that rise as women move through the transition are hot flashes and vaginal dryness.² They’re the first two on this list.

That isn’t a coincidence. Hormone therapy treats what falling estrogen causes, and for those symptoms nothing else works as well. If severe hot flashes are wrecking your sleep, it’s a reasonable thing to want.

What it won’t touch

More than twenty-five symptoms are associated with peri/menopause. Hormone therapy reliably resolves two.

For the rest — the exhaustion, the weight that won’t move, the joints, the fog, the mood that turns without warning — women on hormone therapy commonly find themselves still tired, still heavy, still foggy.

That isn’t the drug failing. Those symptoms were never an estrogen problem.

So the decision about hormones, whichever way you go, leaves most of your list untouched. It doesn’t even address it.

The warnings changed. The science didn’t.

In late 2025, the FDA asked manufacturers to revise the labels on hormone therapy products — removing the boxed-warning language about heart disease, breast cancer and dementia, and removing the old instruction to use the lowest effective dose for the shortest amount of time. It also asked for guidance to be added about starting treatment for severe hot flashes in women under 60 or within ten years of menopause. The FDA approved the first revised labels in early 2026.³

This matters, and it’s worth being precise about what happened.

No new study caused it. The FDA reviewed the existing literature and changed how the risks are described. That’s a change in policy, not a change in the biology.

What it corrects is real, though. The 2002 trial that frightened a generation of women enrolled participants averaging 63.3 years — well past menopause.⁴ Applying those findings to a woman of 50 with severe hot flashes was never sound, and it kept many women from something that would have helped them.

What didn’t change: the studies showing that breast cancer risk rises with the number of years a woman uses systemic hormone therapy.⁵ That finding stands. The FDA’s judgment was that it doesn’t belong in a boxed warning — not that it isn’t there.

Which is why the old “lowest dose, shortest time” formula was half right. The dose half was wrong, and undertreating women was a genuine failure of that era. The duration half wasn’t.

The bone question, which is the clearest case

Hormone therapy protects bone. That’s well established, and it’s one of the approved uses.

Here’s what usually gets left out. When you stop HRT, bone loss resumes. Not a dramatic rebound — just the ordinary postmenopausal loss picking up again where it left off. A review of eleven studies found bone loss after stopping in every one of them, with first-year losses ranging from 2.3% to 6.2%.⁶

So the protection lasts as long as the treatment does, but doesn’t endure.⁷

That leaves a woman taking it for bone with an uncomfortable choice: stop after a short course and lose the protection, or continue for decades — which puts her in the group with the longest exposure and the most accumulated risk.

Meanwhile the natural approach to bone doesn’t work that way. Load-bearing movement, enough protein, and the nutrients your body needs builds bone that stays built. You don’t lose it the month you stop paying attention.

That’s not an argument against hormone therapy for bone. It’s an argument that hormone therapy alone was never a great strategy.

About the fountain of youth

Firmer skin, more energy, the weight coming off, staying young. None of that is among the approved uses, and none of it is what the evidence supports.

Hormone therapy is precise. It treats the things it treats, and it does those well. It isn’t an anti-aging drug, and the people promoting it that way are generally not the ones who’ll be managing the consequences after 15 years of use.

What actually holds your skin, your muscle and your energy together is the same unglamorous work that holds everything else together. There’s no shortcut, and the drug isn’t one.

A word about “bioidentical”

Two different things go by that name.

FDA-approved bioidentical hormones — estradiol and micronized progesterone — are regulated, tested, consistently dosed prescription medicines.

Compounded bioidenticals, mixed at a pharmacy to a custom formula, are not. The menopause societies have flagged minimal regulation, inconsistent dosing, questions about purity and sterility, and no requirement to carry a label listing risks.⁸ ACOG’s own clinical consensus goes further, telling doctors that hormone tests are not recommended for prescribing or dosing compounded hormone therapy, and that most patients don’t need blood-level testing at all — dosing should follow how a woman actually feels.⁹

The pitch is personalization: a formula matched to your hormone levels. But look back at what we covered in Falling estrogen is a weak explanation. Your hormone levels don’t predict your symptoms — that’s why NICE and ACOG tell doctors not to test them.

If levels don’t tell you how a woman feels, dosing to her levels can’t be precision. The saliva and urine testing used to justify these formulas isn’t recommended for setting doses, for exactly that reason.⁸

Custom-compounded doesn’t mean gentler, safer or more natural. It means less tested, sold with a personalization story that the science doesn’t support.

If you take it — and if you don’t

If hormone therapy fits your symptoms and your history, it’s a legitimate option and worth an honest conversation with your doctor. Ask about timing, about type, and about vaginal estrogen specifically if dryness is part of your picture — it’s a local treatment with a more reassuring safety profile than systemic hormones.

But treat it as what it is: precise, effective for a short list of problems, and not for indefinite use.

If you take it, do the underlying work alongside it. Hormones will quiet your hot flashes. They won’t touch the patterns underneath, and those patterns are still shaping your health.

If you don’t, that same work is the whole of your answer, and it’s a better answer than most women realize.

Either way, the question is the same one: which pattern are you carrying, and what does it need?

Where to start

Your symptoms show which pattern you carry into peri/menopause — and which changes will actually work for you, for symptom relief and better health.

That’s what the BioType quiz reads. Twenty-seven questions, five minutes.

Find My BioType